These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 27456360

  • 1. MicroRNA-497 downregulation contributes to cell proliferation, migration, and invasion of estrogen receptor alpha negative breast cancer by targeting estrogen-related receptor alpha.
    Han L, Liu B, Jiang L, Liu J, Han S.
    Tumour Biol; 2016 Oct; 37(10):13205-13214. PubMed ID: 27456360
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 7. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
    Kong LM, Liao CG, Zhang Y, Xu J, Li Y, Huang W, Zhang Y, Bian H, Chen ZN.
    Cancer Res; 2014 Jul 15; 74(14):3764-78. PubMed ID: 24906624
    [Abstract] [Full Text] [Related]

  • 8. A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis.
    Chu HW, Cheng CW, Chou WC, Hu LY, Wang HW, Hsiung CN, Hsu HM, Wu PE, Hou MF, Shen CY, Yu JC.
    Hum Mol Genet; 2014 Jan 15; 23(2):355-67. PubMed ID: 24009311
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERRα.
    Tribollet V, Barenton B, Kroiss A, Vincent S, Zhang L, Forcet C, Cerutti C, Périan S, Allioli N, Samarut J, Vanacker JM.
    PLoS One; 2016 Jan 15; 11(5):e0156445. PubMed ID: 27227989
    [Abstract] [Full Text] [Related]

  • 11. Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer.
    Stein RA, Chang CY, Kazmin DA, Way J, Schroeder T, Wergin M, Dewhirst MW, McDonnell DP.
    Cancer Res; 2008 Nov 01; 68(21):8805-12. PubMed ID: 18974123
    [Abstract] [Full Text] [Related]

  • 12. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
    Lettlova S, Brynychova V, Blecha J, Vrana D, Vondrusova M, Soucek P, Truksa J.
    Cell Physiol Biochem; 2018 Nov 01; 46(6):2601-2615. PubMed ID: 29763890
    [Abstract] [Full Text] [Related]

  • 13. Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.
    Jiang CF, Li DM, Shi ZM, Wang L, Liu MM, Ge X, Liu X, Qian YC, Wen YY, Zhen LL, Lin J, Liu LZ, Jiang BH.
    Oncotarget; 2016 Jun 14; 7(24):36940-36955. PubMed ID: 27175587
    [Abstract] [Full Text] [Related]

  • 14. Estrogen Receptor α (ERα) and Estrogen Related Receptor α (ERRα) are both transcriptional regulators of the Runx2-I isoform.
    Kammerer M, Gutzwiller S, Stauffer D, Delhon I, Seltenmeyer Y, Fournier B.
    Mol Cell Endocrinol; 2013 Apr 30; 369(1-2):150-60. PubMed ID: 23403054
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells.
    de Souza Rocha Simonini P, Breiling A, Gupta N, Malekpour M, Youns M, Omranipour R, Malekpour F, Volinia S, Croce CM, Najmabadi H, Diederichs S, Sahin O, Mayer D, Lyko F, Hoheisel JD, Riazalhosseini Y.
    Cancer Res; 2010 Nov 15; 70(22):9175-84. PubMed ID: 20978187
    [Abstract] [Full Text] [Related]

  • 17. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
    Hui Z, Yiling C, Wenting Y, XuQun H, ChuanYi Z, Hui L.
    FEBS Lett; 2015 Mar 24; 589(7):812-21. PubMed ID: 25725194
    [Abstract] [Full Text] [Related]

  • 18. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.
    Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H.
    Cancer Res; 2008 Jul 01; 68(13):5004-8. PubMed ID: 18593897
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer.
    Endo Y, Yamashita H, Takahashi S, Sato S, Yoshimoto N, Asano T, Hato Y, Dong Y, Fujii Y, Toyama T.
    BMC Cancer; 2014 Dec 20; 14():990. PubMed ID: 25528056
    [Abstract] [Full Text] [Related]

  • 20. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
    Liu F, Zhuang L, Wu R, Li D.
    J BUON; 2019 Dec 20; 24(5):1905-1912. PubMed ID: 31786854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.